Scarica l'app Stockscreener
19.73
0.61%
0.12
Pre-mercato:
19.39
-0.34
-1.72%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$19.61
Aprire:
$19.73
Volume 24 ore:
6.49M
Relative Volume:
0.75
Capitalizzazione di mercato:
$10.14B
Reddito:
$10.89B
Utile/perdita netta:
$-241.00M
Rapporto P/E:
-74.28
EPS:
-0.2656
Flusso di cassa netto:
$340.00M
1 W Prestazione:
-1.69%
1M Prestazione:
+2.49%
6M Prestazione:
-31.59%
1 anno Prestazione:
-39.81%
Intervallo 1D:
$19.23
$19.80
Intervallo di 1 settimana:
$19.23
$20.02
Portata 52W:
$17.40
$37.74
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(224) 948-2000
Indirizzo
ONE BAXTER PARKWAY, DEERFIELD, IL
Confronta BAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
19.73 | 10.08B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
507.55 | 185.06B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
201.09 | 57.53B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.15 | 39.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.61 | 37.62B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.73 | 36.88B | 27.43B | 1.27B | 1.01B | 1.5829 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-31 | Downgrade | Argus | Buy → Hold |
| 2025-08-04 | Downgrade | Stifel | Buy → Hold |
| 2025-08-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Elastomeric Infusion Pumps Market worth $1.49 billion by 2030 at 5.3%, says MarketsandMarkets™ - GlobeNewswire Inc.
Reasons to Retain Baxter International Stock in Your Portfolio Now - Yahoo Finance
Jobs Data: Is Baxter International Inc in a long term uptrend2025 Dividend Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
Baxter’s Strategic Pivot Faces Key Test with Upcoming Earnings - AD HOC NEWS
Baxter International Inc. $BAX Shares Purchased by Cooke & Bieler LP - MarketBeat
Stoneridge Investment Partners LLC Buys Shares of 93,458 Baxter International Inc. $BAX - MarketBeat
Assessing Baxter International (BAX) Valuation After Dynamo Series Stretcher Launch At J.P. Morgan Healthcare Conference - Sahm
Baxter International Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Baxter International Inc. (NYSE:BAX) Receives Consensus Rating of "Reduce" from Analysts - MarketBeat
Baxter International Inc. Stock: Hidden Health-Care Giant or Total Snooze Buy? - AD HOC NEWS
Baxter International (NYSE:BAX) Stock Rating Lowered by Zacks Research - MarketBeat
Baxter International Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains - 富途资讯
FOMO Trade: Is Baxter International Inc stock risky to hold nowJuly 2025 Fed Impact & Daily Price Action Insights - baoquankhu1.vn
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors - marketscreener.com
What you need to know ahead of Baxter International's earnings release - MSN
Aug Chart Watch: Is Baxter International Inc in a long term uptrend2025 Valuation Update & Safe Entry Zone Tips - baoquankhu1.vn
Did Baxter’s New Dynamo Smart Stretcher Launch Just Shift Baxter International's (BAX) Investment Narrative? - Yahoo Finance
Baxter's Room Temperature HEMOPATCH Sealing Hemostat Gains Momentum in Australia and New Zealand - PR Newswire
Baxter International: Transition Year With No Immediate Catalysts (NYSE:BAX) - Seeking Alpha
Assessing Baxter International (BAX) Valuation After Mixed Short And Long Term Shareholder Returns - Yahoo Finance
How Recent Analyst Shifts Are Rewriting The Baxter International (BAX) Investment Story - Yahoo Finance
Big Picture: Will Baxter International Inc be affected by tariffsJuly 2025 Update & High Conviction Trade Alerts - baoquankhu1.vn
Sentiment Review: Is SEAT a top pick in the sectorQuarterly Market Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Baxter International Stock: Quiet Turnaround Play Or Value Trap In Healthcare Tech? - AD HOC NEWS
What To Be Aware Of Before Baxter International Announces Its Earnings - Bitget
Baxter International Inc. (BAX) Stock Analysis: Exploring a 15% Potential Upside Amidst Strategic Global Operations - directorstalkinterviews.com
What You Need To Know Ahead of Baxter International's Earnings Release - Barchart.com
Sodium Chloride Injections Market, Global Forecast 2026-2032 - GlobeNewswire Inc.
The Bottom Fishing ClubBaxter: Defensive Pick, Restructuring And Paying Down Debt (BAX) - Seeking Alpha
Baxter International (NYSE:BAX) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Baxter International (BAX) Faces Weak EPS Revision Grades - GuruFocus
Goldman Sachs Adjusts Price Target on Baxter International to $21 From $23, Maintains Neutral Rating - marketscreener.com
Lobbying Update: $60,000 of BAXTER HEALTHCARE CORPORATION lobbying was just disclosed - Quiver Quantitative
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety - The Globe and Mail
Manning & Napier Advisors LLC Sells 51,029 Shares of Baxter International Inc. $BAX - MarketBeat
Baxter introduces new hospital stretcher - MassDevice
Baxter International Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Baxter CEO outlines plan to slash debt, boost pipeline in 2026 - chicagobusiness.com
Baxter International Inc. Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in HospitalSettings - marketscreener.com
BaxterDynamo series is now available for order in the U.S. and is expected to be available during the first half of 2026 - marketscreener.com
Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings - rutlandherald.com
Baxter Introduces the Dynamo Series, A New Smart Stretcher to Help Address Common Challenges in Hospital Settings - Baxter
Does Baxter International (BAX) Now Look Fairly Priced After Multi‑Year Share Price Slide - Yahoo Finance
Baxter International Inc. stock underperforms Monday when compared to competitors - MSN
Why Baxter (BAX) Stock Is Trading Lower Today - The Globe and Mail
Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential Amidst a 10.43% Upside - DirectorsTalk Interviews
Stock Traders Buy Large Volume of Baxter International Put Options (NYSE:BAX) - MarketBeat
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges - Bioscience Association Manitoba
The Truth About Baxter International Inc.: Why Wall Street Suddenly Can’t Ignore It - AD HOC NEWS
SG Americas Securities LLC Grows Stock Holdings in Baxter International Inc. $BAX - MarketBeat
Barclays Cuts Baxter International (NYSE:BAX) Price Target to $30.00 - MarketBeat
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):